# a4b7 Integrin in Eosinophilic Esophagitis

> **NCT02546219** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 16 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **OTHER:** Eosinophil isolation and characterization.

## Key facts

- **NCT ID:** NCT02546219
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02546219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02546219, "a4b7 Integrin in Eosinophilic Esophagitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02546219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*